Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Daniel Rubio

Orthopaedic Surgery of the Spine New Haven, CT Medical Doctor

NPI 1639598212 CMS profile 6924088

47 College St Fl 2, New Haven, CT 06510

Open in the dashboard

General payments

$38,637

233 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$17,018 paid to institutions, not to them · program years 2024–2025

Through program year 2025, Daniel Rubio of New Haven, CT is reported in the CMS Open Payments database as having received $38,637 across 233 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $17,018 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 66th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,025 25
2024 General $1,257 31
2023 General $2,547 38
2022 General $16,136 54
2021 General $12,388 42
2020 General $649 11
2019 General $4,634 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Daniel Rubio
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Daniel Rubio were reported at $1,025. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Daniel Rubio Orthopaedic Surgery of the Spine median Middle half National median
2019 $4,634 $2,106 $337–$18,608 $163
2020 $649 $1,213 $156–$15,082 $114
2021 $12,388 $1,834 $271–$15,617 $132
2022 $16,136 $2,015 $320–$17,036 $149
2023 $2,547 $1,925 $336–$14,599 $160
2024 $1,257 $2,110 $341–$12,483 $164
2025 $1,025 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. DePuy Synthes Products, Inc. $10,843 14 payments
  2. SI-BONE, Inc. $9,114 32 payments
  3. Alphatec Spine, Inc $6,875 16 payments
  4. Medtronic, Inc. $3,410 75 payments
  5. Medtronic USA, Inc. $3,121 23 payments
  6. NuVasive, Inc. $1,330 20 payments
  7. DePuy Synthes Sales Inc. $923 20 payments
  8. Globus Medical, Inc. $797 5 payments
  9. Stryker Corporation $783 10 payments
  10. Synthes GmbH $662 1 payment
  11. Other $780 17 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $16,946 5 payments
  2. Travel and Lodging $10,820 29 payments
  3. Food and Beverage $10,806 198 payments
  4. Entertainment $66 1 payment
Products named General payments · program years 2019–2025
  1. IFUSE IMPLANT $7,430 15 payments
  2. Other - Miscellaneous $4,760 8 payments
  3. CD HORIZON $2,280 16 payments
  4. STEALTH AUTOGUIDE SYSTEM $1,127 10 payments
  5. XLIF $982 12 payments
  6. MAZOR X SYSTEM $858 19 payments
  7. EXCELSIUS GPS $797 5 payments
  8. O-ARM-Spine $648 4 payments
  9. Spinal-Stim $355 12 payments
  10. Invictus OPEN $345 1 payment
  11. Other $4,340 97 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

16

Median for Orthopedic Surgery: 203

Drug cost

$34

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Meloxicam Generic 16 $34

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 20 billing codes

Paid by Medicare

$31,646

Medicare's payments for the services billed

Medicare patients

153

Average age 73

Services billed

239

82 women, 71 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 35%
Ischemic heart disease 33%
Diabetes 31%
Osteoporosis 24%
Heart failure 20%
COPD 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

233 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Connecticut

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record